Normal view MARC view ISBD view

Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases.

Joharapurkar, Amit A

Prolyl Hydroxylase Inhibitors: A Breakthrough in the Therapy of Anemia Associated with Chronic Diseases. [electronic resource] - Journal of medicinal chemistry 08 2018 - 6964-6982 p. digital

Publication Type: Journal Article; Review

ISSN: 1520-4804

Standard No.: 10.1021/acs.jmedchem.7b01686 doi

Subjects--Topical Terms:
Anemia--drug therapy
Genetic Diseases, Inborn--drug therapy
Humans
Inflammatory Bowel Diseases--drug therapy
Neoplasms--drug therapy
Prolyl-Hydroxylase Inhibitors--chemistry
Renal Insufficiency, Chronic--drug therapy

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)